Enlivex Therapeutics Ltd Stock Ownership - Who owns Enlivex Therapeutics?

Insider buying vs selling

Have Enlivex Therapeutics Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ENLV insiders and whales buy or sell their stock.

ENLV Shareholders

What type of owners hold Enlivex Therapeutics Ltd stock?
Digital Generation Inc57.80%10,750,000$19.14MInsider
James Crabbe16.91%3,145,600$5.60MInsider
Dan Isaacs1.08%201,299$358.31kInsider
Adam Moore1.08%201,299$358.31kInsider
Compagnie Lombard Odier Scma0.35%65,000$115.70kInstitution
Renaissance Technologies LLC0.32%58,889$104.82kInstitution
Jerry S. Amato0.27%50,000$89.00kInsider
Morgan Stanley0.24%44,156$78.60kInstitution
Citadel Advisors LLC0.20%37,683$67.08kInstitution
William Hayward Mitchell0.08%14,500$25.81kInsider

1 of 3

ENLV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INAB7.74%15.44%Net BuyingNet Buying

Enlivex Therapeutics Stock Ownership FAQ

Who owns Enlivex Therapeutics?

Enlivex Therapeutics (NASDAQ: ENLV) is owned by 1.39% institutional shareholders, 77.27% Enlivex Therapeutics insiders, and 21.35% retail investors. Digital Generation Inc is the largest individual Enlivex Therapeutics shareholder, owning 10.75M shares representing 57.80% of the company. Digital Generation Inc's Enlivex Therapeutics shares are currently valued at $18.38M.

If you're new to stock investing, here's how to buy Enlivex Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.